Pub Date : 2017-09-26DOI: 10.4172/2161-0932.1000452
T. Ja, M. Aboubakar, Tognifode, Lokossou M.S.H.S, O. Aaa, K. Salifou, E. Assogba, R. Perrin
Objective: To take a census of side effects related to the use of hormonal contraception reported by the women received in the Family Planning (FP) Service of CHU-MEL. Patients and methods: It was a cross-sectional prospective study which was carried out in the family planning service ofCHU-MEL in Cotonouover a three-month period from June 1st to August 31st, 2016. Results: 303 women were involved in this survey. The average age was 33 years (extremes of 15 and 49 years).Side effects were vaginal bleeding apart from the menses (37.2%) amenorrhea (32%) and weight increase (27.3%). The reasons for abandonment of hormonal contraceptionwere amenorrhea (13%), weight gain (11%), pelvic pain (0.07), nausea (0.05%) and bleeding (0.04). Conclusion: Hormonal contraception has many side effects. Some of them are well known by patients. They influence compliance with treatment. Their management is not always optimal and leads to abandonment.
{"title":"Side Effects of Hormonal Contraception of Patients in the Family Planning of Centre University Hospital of Mother and Child Lagoon, Cotonou (Benin)","authors":"T. Ja, M. Aboubakar, Tognifode, Lokossou M.S.H.S, O. Aaa, K. Salifou, E. Assogba, R. Perrin","doi":"10.4172/2161-0932.1000452","DOIUrl":"https://doi.org/10.4172/2161-0932.1000452","url":null,"abstract":"Objective: To take a census of side effects related to the use of hormonal contraception reported by the women received in the Family Planning (FP) Service of CHU-MEL. \u0000Patients and methods: It was a cross-sectional prospective study which was carried out in the family planning service ofCHU-MEL in Cotonouover a three-month period from June 1st to August 31st, 2016. \u0000Results: 303 women were involved in this survey. The average age was 33 years (extremes of 15 and 49 years).Side effects were vaginal bleeding apart from the menses (37.2%) amenorrhea (32%) and weight increase (27.3%). The reasons for abandonment of hormonal contraceptionwere amenorrhea (13%), weight gain (11%), pelvic pain (0.07), nausea (0.05%) and bleeding (0.04). \u0000Conclusion: Hormonal contraception has many side effects. Some of them are well known by patients. They influence compliance with treatment. Their management is not always optimal and leads to abandonment.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"912 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2017-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85526459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-09-22DOI: 10.4172/2161-0932.1000453
Frhana Rahmat, H. Ithnin
Ovarian cancer is the fifth most common cause of cancer death in women worldwide and is the fourth leading cause of cancer related deaths in Malaysia. Ovarian cancer are classified based on histological types, because it is an important surrogate for genetic, prognostic, and predictive information about response to treatment. The malignant epithelial tumor, that is ovarian carcinoma (OC) is the most common group and the four most common subtypes of OC are serous, endometrioid, clear cell and mucinous. Among the OC, ovarian serous carcinoma (OSC) is the most common subtypes. Most of the women with OC presented with locally advanced disease or distant metastasized at the time of diagnosis. The two-tier grading system (also known as MDACC [M.D Anderson Cancer Center] grading system) has been accepted worldwide. Human epididymis 4 (HE4) is a new protein which is frequently overexpressed in ovarian neoplastic tissue. Previous studies have shown that there is significant difference of HE4 expression in low grade serous carcinoma (LGSC) and high grade serous carcinoma (HGSC). The aim of this study is to further evaluate the HE4 tissue expression in 2 different grades of OSC in Hospital Serdang. This is a retrospective, cross-sectional study, of 71 cases histopathologically diagnosed as OSC comprising of 48 cases of HGSC and 23 cases of LGSC. Cases were collected from Hospital Serdang, from 1st January 2006 to 31st December 2013. All cases were examined for HE4 expression by immunohistochemistry using anti-HE4 (Polyclonal rabbit antibody dilution 1:40, Abcam).
{"title":"Immunohistochemical Expression of Human Epididymis 4 (He4) in Ovarian Serous Carcinoma in Hospital Serdang from the Year 2006- 2013","authors":"Frhana Rahmat, H. Ithnin","doi":"10.4172/2161-0932.1000453","DOIUrl":"https://doi.org/10.4172/2161-0932.1000453","url":null,"abstract":"Ovarian cancer is the fifth most common cause of cancer death in women worldwide and is the fourth leading cause of cancer related deaths in Malaysia. Ovarian cancer are classified based on histological types, because it is an important surrogate for genetic, prognostic, and predictive information about response to treatment. The malignant epithelial tumor, that is ovarian carcinoma (OC) is the most common group and the four most common subtypes of OC are serous, endometrioid, clear cell and mucinous. Among the OC, ovarian serous carcinoma (OSC) is the most common subtypes. Most of the women with OC presented with locally advanced disease or distant metastasized at the time of diagnosis. The two-tier grading system (also known as MDACC [M.D Anderson Cancer Center] grading system) has been accepted worldwide. Human epididymis 4 (HE4) is a new protein which is frequently overexpressed in ovarian neoplastic tissue. Previous studies have shown that there is significant difference of HE4 expression in low grade serous carcinoma (LGSC) and high grade serous carcinoma (HGSC). The aim of this study is to further evaluate the HE4 tissue expression in 2 different grades of OSC in Hospital Serdang. \u0000This is a retrospective, cross-sectional study, of 71 cases histopathologically diagnosed as OSC comprising of 48 cases of HGSC and 23 cases of LGSC. Cases were collected from Hospital Serdang, from 1st January 2006 to 31st December 2013. All cases were examined for HE4 expression by immunohistochemistry using anti-HE4 (Polyclonal rabbit antibody dilution 1:40, Abcam).","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"1 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2017-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88776094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-09-20DOI: 10.4172/2161-0932.1000451
B. Pellicer-Iborra, S. Herraiz, A. Morales, S. Martínez, N. Garrido, A. Pellicer
Mifepristone (RU486) it is known as an effective abortifacient and postcoital contraceptive method, whose mechanism is not yet known. We carried on a pilot study with the aim of determining the effect that Mifepristone could have in utero-placental vascular compartment during the first trimester of pregnancy compared with placebo. This is a randomized, double-blind, placebo-controlled research. We randomly assigned to two groups patients requesting pregnancy termination with a gestational age between 9th and 11st weeks: Group A receiving placebo and Group B receiving RU. With transvaginal ultrasound tridimensional probe we measured at an initial time (t1) and then 4 hours after administration of Mifepristone or placebo (t2) Doppler parameters: uterine arteries mean Resistance Index, spiral arteries Resistance Index, intervillous flow, umbilical Resistance Index and tridimensional vascular settings and the placental volume. We observed how Mifepristone shows an immediate selective hemodynamic effect in trophoblastic tissue in the first hours of administration. A significant decrease in spiral arteries pulsatility index was demonstrated, without modifying uterine maternal and fetal territories or the other studied parameters. Angiopower 3D evaluation of the interface maternal fetal is complex and encourages to carry further investigations carry further investigations.
{"title":"Three-Dimensional Angiogenic Evaluation of the Effect of Mifepristone in Early Gestation: Pilot Study","authors":"B. Pellicer-Iborra, S. Herraiz, A. Morales, S. Martínez, N. Garrido, A. Pellicer","doi":"10.4172/2161-0932.1000451","DOIUrl":"https://doi.org/10.4172/2161-0932.1000451","url":null,"abstract":"Mifepristone (RU486) it is known as an effective abortifacient and postcoital contraceptive method, whose mechanism is not yet known. We carried on a pilot study with the aim of determining the effect that Mifepristone could have in utero-placental vascular compartment during the first trimester of pregnancy compared with placebo. This is a randomized, double-blind, placebo-controlled research. We randomly assigned to two groups patients requesting pregnancy termination with a gestational age between 9th and 11st weeks: Group A receiving placebo and Group B receiving RU. With transvaginal ultrasound tridimensional probe we measured at an initial time (t1) and then 4 hours after administration of Mifepristone or placebo (t2) Doppler parameters: uterine arteries mean Resistance Index, spiral arteries Resistance Index, intervillous flow, umbilical Resistance Index and tridimensional vascular settings and the placental volume. We observed how Mifepristone shows an immediate selective hemodynamic effect in trophoblastic tissue in the first hours of administration. A significant decrease in spiral arteries pulsatility index was demonstrated, without modifying uterine maternal and fetal territories or the other studied parameters. Angiopower 3D evaluation of the interface maternal fetal is complex and encourages to carry further investigations carry further investigations.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"1 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2017-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81599772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-09-04DOI: 10.4172/2161-0932.1000450
Camara Mk, Williams Ld, K. Diarra, M. Mamoudou, B. Ousmane, K. Namory
It was a retrospective and descriptive study based on the calculation of the frequency, and to describe the clinical epidemiology, anatomopathologics and therapeutics aspects of the vulva cancers recorded between 1st of January 2005 to 31st of December 2014 at the service. We recorded 12 cases with Medium Age of 54 years, with extremity of 22 years and 84 years. We noted 1% of vulva cancer among the 1234 cases of Gynecological cancers diagnosed in the service. Two- third of the patients were elder than 55 years and the multiparous with 75%. The prurition and the tumefaction were the principal motive of consultation among 41.66 %. The tumor had epithelial origin in the clinical stage III in 50% of cases according to FIGO (2009). 3.6% of vulvectomy associated with lymphadenectomy in two-third and one case of radiotherapy. The cancers cases recorded were invasive epithelium type in old age women. These were intended to allow precocious diagnose and adequate taking care of the disease.
{"title":"Invasive Cancer of the Vulva: Clinical and Therapeutic Aspects in the Gynecology and Obstetrics Service at Donka Hospital, Guinea- Conakry","authors":"Camara Mk, Williams Ld, K. Diarra, M. Mamoudou, B. Ousmane, K. Namory","doi":"10.4172/2161-0932.1000450","DOIUrl":"https://doi.org/10.4172/2161-0932.1000450","url":null,"abstract":"It was a retrospective and descriptive study based on the calculation of the frequency, and to describe the clinical epidemiology, anatomopathologics and therapeutics aspects of the vulva cancers recorded between 1st of January 2005 to 31st of December 2014 at the service. We recorded 12 cases with Medium Age of 54 years, with extremity of 22 years and 84 years. \u0000We noted 1% of vulva cancer among the 1234 cases of Gynecological cancers diagnosed in the service. \u0000Two- third of the patients were elder than 55 years and the multiparous with 75%. \u0000The prurition and the tumefaction were the principal motive of consultation among 41.66 %. \u0000The tumor had epithelial origin in the clinical stage III in 50% of cases according to FIGO (2009). \u00003.6% of vulvectomy associated with lymphadenectomy in two-third and one case of radiotherapy. \u0000The cancers cases recorded were invasive epithelium type in old age women. These were intended to allow precocious diagnose and adequate taking care of the disease.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"25 8","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2017-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72397255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-08-30DOI: 10.4172/2161-0932.1000449
S. Mahboobeh, A. Fatemeh, S. Mamak, P. Reihaneh, S. Nafiseh
Background: Abortion is the most common subjects of obstetric which has applied two methods including surgical and medical approaches. Pain is the most common complication of medical abortion and pain relief is one the most important items in these patients. Objectives: Evaluated the effect of three non-steroidal anti-inflammatory drugs in pain reduction of medical abortion in less than 14 weeks gestation with forensics declaration. Methods: This study was a retrospective cohort in 66 pregnant women with less than 14 weeks gestation referred to Yas hospital for medical abortion that were assigned to three groups based on sedative drugs: A) Mefenamic acid capsules 250 mg, B) Diclofenac tablets 100 mg and C) Ibuprofen tablets 400 mg. The standardized visual assessment scale was assessed before and after drug administration that presented in medical records of patients. Results: Comparison of visual assessment scale means before and after using of three non-steroidal antiinflammatory drugs demonstrated that all three drugs lead to pain relief after the abortion that was significant statistically (P value=0.001). There was a significant difference in termination time of pregnancy between three groups, (P value= 0.016). In the case of hemoglobin drop, diclofenac lead to the lowest hemoglobin drop (P value=0.004). The amount of receiving narcotic among three groups revealed the significant difference (P value= 0.000). There were not significant differences in pain relief (P value=0.327) and demographic data between three groups. Conclusion: It was indicated that the three NSAIDs drugs, had a significant effect on the management of pain, diclofenac expended less termination time of pregnancy, narcotic drug usage and also hemoglobin drop than other groups. What does this study add? Non-steroidal anti-inflammatory drugs are effective in pain management of medical abortion and some of them are preferred to others. Diclofenac can reduce abortion time and also hemoglobin drop after abortion and additional dose of other narcotics too.
{"title":"Pain Control of Medical Abortion with Misoprostol in the First Trimester of Pregnancy","authors":"S. Mahboobeh, A. Fatemeh, S. Mamak, P. Reihaneh, S. Nafiseh","doi":"10.4172/2161-0932.1000449","DOIUrl":"https://doi.org/10.4172/2161-0932.1000449","url":null,"abstract":"Background: Abortion is the most common subjects of obstetric which has applied two methods including surgical and medical approaches. Pain is the most common complication of medical abortion and pain relief is one the most important items in these patients. \u0000Objectives: Evaluated the effect of three non-steroidal anti-inflammatory drugs in pain reduction of medical abortion in less than 14 weeks gestation with forensics declaration. \u0000Methods: This study was a retrospective cohort in 66 pregnant women with less than 14 weeks gestation referred to Yas hospital for medical abortion that were assigned to three groups based on sedative drugs: A) Mefenamic acid capsules 250 mg, B) Diclofenac tablets 100 mg and C) Ibuprofen tablets 400 mg. The standardized visual assessment scale was assessed before and after drug administration that presented in medical records of patients. \u0000Results: Comparison of visual assessment scale means before and after using of three non-steroidal antiinflammatory drugs demonstrated that all three drugs lead to pain relief after the abortion that was significant statistically (P value=0.001). There was a significant difference in termination time of pregnancy between three groups, (P value= 0.016). In the case of hemoglobin drop, diclofenac lead to the lowest hemoglobin drop (P value=0.004). The amount of receiving narcotic among three groups revealed the significant difference (P value= 0.000). There were not significant differences in pain relief (P value=0.327) and demographic data between three groups. \u0000Conclusion: It was indicated that the three NSAIDs drugs, had a significant effect on the management of pain, diclofenac expended less termination time of pregnancy, narcotic drug usage and also hemoglobin drop than other groups. \u0000What does this study add? Non-steroidal anti-inflammatory drugs are effective in pain management of medical abortion and some of them are preferred to others. Diclofenac can reduce abortion time and also hemoglobin drop after abortion and additional dose of other narcotics too.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"67 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2017-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84079582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-08-26DOI: 10.4172/2161-0932.1000448
M. Stracquadanio, M. Giunta, A. D'Agati, C. Pafumi, L. Ciotta, M. Palumbo
The Hormone Replacement Therapy (HRT) is the "first-line therapy" for women with moderate / severe menopausal symptoms (hot flashes, profuse sweating, insomnia, osteoporosis). However, when the symptomatology is lighter or there are contraindications to HRT (breast disease, cardiovascular disease, thrombophilic diathesis, smoke, etc), woman can benefit from some preparations such as phytoestrogens and Cimicifuga racemosa. At present there are insufficient data regarding the efficacy and safety of phytoestrogens in women with breast cancer: because this tumour disease is hormone-dependent, phytoestrogens should be considered contraindicated in patients survived to the disease. Our study assessed both the effectiveness of a new compound containing Cimicifuga racemosa, Agnus-Castus, Ginger, Hyaluronic acid and Zinc on the neurovegetative menopausal symptoms (hot flashes, profuse sweating, insomnia) and its safe use in patients with breast cancer. The results have shown that this compound is an excellent alternative to estrogen treatment of menopausal neurovegetative symptoms, even for patients with breast cancer who cannot take HRT or phytoestrogens.
{"title":"Efficacy of a New Compound Containing Cimicifuga Racemosa on Menopausal Symptoms in Women with Breast Cancer","authors":"M. Stracquadanio, M. Giunta, A. D'Agati, C. Pafumi, L. Ciotta, M. Palumbo","doi":"10.4172/2161-0932.1000448","DOIUrl":"https://doi.org/10.4172/2161-0932.1000448","url":null,"abstract":"The Hormone Replacement Therapy (HRT) is the \"first-line therapy\" for women with moderate / severe \u0000 menopausal symptoms (hot flashes, profuse sweating, insomnia, osteoporosis). \u0000However, when the symptomatology is lighter or there are contraindications to HRT (breast disease, \u0000 cardiovascular disease, thrombophilic diathesis, smoke, etc), woman can benefit from some preparations such as \u0000 phytoestrogens and Cimicifuga racemosa. At present there are insufficient data regarding the efficacy and safety of \u0000 phytoestrogens in women with breast cancer: because this tumour disease is hormone-dependent, phytoestrogens \u0000 should be considered contraindicated in patients survived to the disease. \u0000Our study assessed both the effectiveness of a new compound containing Cimicifuga racemosa, Agnus-Castus, \u0000 Ginger, Hyaluronic acid and Zinc on the neurovegetative menopausal symptoms (hot flashes, profuse sweating, \u0000 insomnia) and its safe use in patients with breast cancer. \u0000The results have shown that this compound is an excellent alternative to estrogen treatment of menopausal \u0000 neurovegetative symptoms, even for patients with breast cancer who cannot take HRT or phytoestrogens.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"1 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2017-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73150973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-08-18DOI: 10.4172/2161-0932.1000447
T. Ja, Lokossou Mshs, F. Aboubakar, H. Bib, O. Aaa, K. Salifou, A. Lokossou, Perrin Rx
Objectives: To evaluate professionals practices and the contribution of magnesium sulphate in a better medical care for persons with severe preeclampsia at CHU-MEL. Materials and Method: We conducted a retrospective and cross-sectional study with the aim come up with a descriptive and analytical paper. Our study was conducted from January 15th, 2015 to July 15th, 2016, i.e. during eighteen (18) months. The sampling was exhaustive. The population was made of all patients admitted for severe preeclampsia with or without complications. Confidentiality requirements were met and informed consent obtained from all subjects. For the analytical study, the chi-square test was used and the difference was statistically significant with a p-value inferior than 0.05. Results: The prevalence of preeclampsia during the study period was 7.70% (447/5805 deliveries). Out of the 312 files that we were able to find and exploit, 272 revealed that patients were administrated a dose of magnesium sulphate, at a frequency estimated at 87.18%. Irregularities were noted in the protocol implementation: the maintenance dose was administered in 30% of cases, as a slow infusion (66.33%), for less than 24 hours in 37.24% of cases, and under supervision only in 22.62% of cases. Primary and secondary prevention of eclampsia was achieved in 98.5% and 80% of cases, respectively. Respecting the duration of treatment significantly reduces the onset and recurrence of seizures (p=0.003 and p=0.004). Decreased reflexes and respiratory distress were noted in 34.78% and in 8.7% of cases respectively. The maternal lethality rate was 1.34% and the stillbirth rate was 11.40%. Conclusion: Magnesium sulphate intake is undeniable in dealing with severe preeclampsia, but this solution/ drug is misused at the CHU-MEL. Appropriate solutions must therefore be taken in the execution and monitoring of the protocol.
{"title":"Use of Magnesium Sulphate in the Management of Severe Preeclampsia at the Centre University Hospital of Mother and Child (CHU-MEL) Cotonou Benin","authors":"T. Ja, Lokossou Mshs, F. Aboubakar, H. Bib, O. Aaa, K. Salifou, A. Lokossou, Perrin Rx","doi":"10.4172/2161-0932.1000447","DOIUrl":"https://doi.org/10.4172/2161-0932.1000447","url":null,"abstract":"Objectives: To evaluate professionals practices and the contribution of magnesium sulphate in a better medical care for persons with severe preeclampsia at CHU-MEL. \u0000Materials and Method: We conducted a retrospective and cross-sectional study with the aim come up with a descriptive and analytical paper. Our study was conducted from January 15th, 2015 to July 15th, 2016, i.e. during eighteen (18) months. The sampling was exhaustive. The population was made of all patients admitted for severe preeclampsia with or without complications. Confidentiality requirements were met and informed consent obtained from all subjects. For the analytical study, the chi-square test was used and the difference was statistically significant with a p-value inferior than 0.05. \u0000Results: The prevalence of preeclampsia during the study period was 7.70% (447/5805 deliveries). Out of the 312 files that we were able to find and exploit, 272 revealed that patients were administrated a dose of magnesium sulphate, at a frequency estimated at 87.18%. Irregularities were noted in the protocol implementation: the maintenance dose was administered in 30% of cases, as a slow infusion (66.33%), for less than 24 hours in 37.24% of cases, and under supervision only in 22.62% of cases. Primary and secondary prevention of eclampsia was achieved in 98.5% and 80% of cases, respectively. Respecting the duration of treatment significantly reduces the onset and recurrence of seizures (p=0.003 and p=0.004). Decreased reflexes and respiratory distress were noted in 34.78% and in 8.7% of cases respectively. The maternal lethality rate was 1.34% and the stillbirth rate was 11.40%. \u0000Conclusion: Magnesium sulphate intake is undeniable in dealing with severe preeclampsia, but this solution/ drug is misused at the CHU-MEL. Appropriate solutions must therefore be taken in the execution and monitoring of the protocol.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"16 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2017-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74529284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-08-05DOI: 10.4172/2161-0932.1000446
A. Nwaneri, Ndie Ec, I. Ehiemere, E. Okafor, E. Po, A. Emeh
This study aimed at evaluating factors that impede utilization and those that promote the utilization partograph by nurses/midwives in monitoring labour in primary/secondary health facilities in Enugu metropolis. Seven health facilities were selected using convenience sampling method. One hundred and twenty six nurses/midwives were used while self- structured questionnaire was used as instrument of data collection. The findings of this study revealed that majority of the nurses/ midwives face a lot of challenges in utilizing the partograph. Some of the major factors that impede the utilization include lack of knowledge of the partograph 68(54%) and inability to interpret findings correctly after assessment with the partograph (73.8%). The major factors that can promote the utilization of partograph include provision of necessary resources such as observation tools (83.3%) like sphygmomanometer, fetoscope and provision of partograph charts in the labour wards (69%). It was concluded that the major factors in the nurses/ midwives that impede the utilization of partograph includes lack of knowledge, inability to interpret findings correctly after assessment with the partograph and that partograph is an additional time consuming task for the inadequate staff. It is recommended that all nurses/ midwives should work towards self-development through education to increase knowledge and skill on partograph use. Management should stand up for their responsibility to encourage and sponsor seminars/workshops as well as conferences on partograph use for quality client care.
{"title":"Evaluation of Factors Affecting the Utilization of Partograph by Nurses/ Midwives in Primary/Secondary Health Facilities in Enugu Metropolis","authors":"A. Nwaneri, Ndie Ec, I. Ehiemere, E. Okafor, E. Po, A. Emeh","doi":"10.4172/2161-0932.1000446","DOIUrl":"https://doi.org/10.4172/2161-0932.1000446","url":null,"abstract":"This study aimed at evaluating factors that impede utilization and those that promote the utilization partograph by nurses/midwives in monitoring labour in primary/secondary health facilities in Enugu metropolis. Seven health facilities were selected using convenience sampling method. One hundred and twenty six nurses/midwives were used while self- structured questionnaire was used as instrument of data collection. The findings of this study revealed that majority of the nurses/ midwives face a lot of challenges in utilizing the partograph. Some of the major factors that impede the utilization include lack of knowledge of the partograph 68(54%) and inability to interpret findings correctly after assessment with the partograph (73.8%). The major factors that can promote the utilization of partograph include provision of necessary resources such as observation tools (83.3%) like sphygmomanometer, fetoscope and provision of partograph charts in the labour wards (69%). It was concluded that the major factors in the nurses/ midwives that impede the utilization of partograph includes lack of knowledge, inability to interpret findings correctly after assessment with the partograph and that partograph is an additional time consuming task for the inadequate staff. It is recommended that all nurses/ midwives should work towards self-development through education to increase knowledge and skill on partograph use. Management should stand up for their responsibility to encourage and sponsor seminars/workshops as well as conferences on partograph use for quality client care.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"22 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2017-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84402856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-28DOI: 10.4172/2161-0932.1000445
M. Niang, Y. Gaye, A. Mbodj, M. Thiam, Cisse Ct
Objectives: To determine the factors influencing the mode of delivery in case of fetal macrosomia. Materials and Methods: That was a retrospective, descriptive and analytical study carried out from October 1st 2010 to March 31st 2013 at the maternity of Gaspard Kamara Health Center in Dakar. A multivariate analysis using logistic regression was used to determine the factors which influence the mode of delivery in case of fetal macrosomia. Results: We collected 333 delivery records of macrosome on 10639 registered births, a rate of 3.1%. Two hundred and fifteen (215) patients met the inclusion criteria. The labor’s test was performed in 55.3% of patients with a failure rate of 15.1%. Caesarean section was performed in 22.8% of patients. The main indications were: acute fetal distress (36.7%), the fetal-pelvic disproportion (26.5%), premature rupture of membranes (12.2%), the extended labor (10.2%), and the lack of engagement (10.2%). All newborns had Apgar score in the fifth minute greater than or equal to 7. The factors that influenced the type of delivery were: fetal weight above 4300 g (p=0.007), nulliparity (p<0.001) and a uterine height upper than 34 cm (p=0.034). Conclusion: In case of fetal macrosomia, fetal weight above 4300 g, nulliparity and the upper uterine height 34 cm are associated with a higher incidence of caesarean delivery.
目的:探讨影响巨大儿分娩方式的因素。材料和方法:这是一项回顾性、描述性和分析性研究，于2010年10月1日至2013年3月31日在达喀尔Gaspard Kamara健康中心的产科进行。采用logistic回归方法对影响巨大儿分娩方式的因素进行多因素分析。结果:在10639例新生儿中收集到巨体分娩记录333例，分娩率3.1%。215例患者符合纳入标准。产程检查成功率为55.3%，失败率为15.1%。22.8%的患者行剖腹产手术。主要指征为:急性胎儿窘迫(36.7%)、胎盆比例失调(26.5%)、胎膜早破(12.2%)、产程延长(10.2%)、未接合(10.2%)。所有新生儿的阿普加评分在第五分钟大于等于7分。影响分娩类型的因素为:胎重大于4300 g (p=0.007)、无产(p<0.001)和子宫高度大于34 cm (p=0.034)。结论:巨大儿、胎重4300 g以上、宫位及上宫高度34 cm与剖宫产发生率较高有关。
{"title":"Indication of caesarean section in the childbirth of a macrosome in a Level 2 Health Center in Dakar","authors":"M. Niang, Y. Gaye, A. Mbodj, M. Thiam, Cisse Ct","doi":"10.4172/2161-0932.1000445","DOIUrl":"https://doi.org/10.4172/2161-0932.1000445","url":null,"abstract":"Objectives: To determine the factors influencing the mode of delivery in case of fetal macrosomia. \u0000Materials and Methods: That was a retrospective, descriptive and analytical study carried out from October 1st 2010 to March 31st 2013 at the maternity of Gaspard Kamara Health Center in Dakar. A multivariate analysis using logistic regression was used to determine the factors which influence the mode of delivery in case of fetal macrosomia. \u0000Results: We collected 333 delivery records of macrosome on 10639 registered births, a rate of 3.1%. Two hundred and fifteen (215) patients met the inclusion criteria. The labor’s test was performed in 55.3% of patients with a failure rate of 15.1%. Caesarean section was performed in 22.8% of patients. The main indications were: acute fetal distress (36.7%), the fetal-pelvic disproportion (26.5%), premature rupture of membranes (12.2%), the extended labor (10.2%), and the lack of engagement (10.2%). All newborns had Apgar score in the fifth minute greater than or equal to 7. The factors that influenced the type of delivery were: fetal weight above 4300 g (p=0.007), nulliparity (p<0.001) and a uterine height upper than 34 cm (p=0.034). \u0000Conclusion: In case of fetal macrosomia, fetal weight above 4300 g, nulliparity and the upper uterine height 34 cm are associated with a higher incidence of caesarean delivery.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"17 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2017-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81973525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：